Data as of Jun 17
| -1.36 / -1.92%|
The 13 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 74.00, with a high estimate of 92.00 and a low estimate of 66.00. The median estimate represents a +6.47% increase from the last price of 69.50.
The current consensus among 14 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.